ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 73 filers reported holding ENTELLUS MED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $671,000 | +78.9% | 27,587 | +35.2% | 0.00% | – |
| Q3 2017 | $375,000 | -7.2% | 20,400 | -16.7% | 0.00% | – |
| Q2 2017 | $404,000 | +1516.0% | 24,495 | +1234.2% | 0.00% | – |
| Q1 2017 | $25,000 | -70.2% | 1,836 | -59.0% | 0.00% | – |
| Q4 2016 | $84,000 | +211.1% | 4,477 | +261.6% | 0.00% | – |
| Q3 2016 | $27,000 | +35.0% | 1,238 | +8.0% | 0.00% | – |
| Q2 2016 | $20,000 | -16.7% | 1,146 | -18.3% | 0.00% | – |
| Q1 2016 | $24,000 | +9.1% | 1,403 | +3.1% | 0.00% | – |
| Q4 2015 | $22,000 | -18.5% | 1,361 | -10.5% | 0.00% | – |
| Q3 2015 | $27,000 | -20.6% | 1,521 | +14.7% | 0.00% | – |
| Q2 2015 | $34,000 | – | 1,326 | +18842.9% | 0.00% | – |
| Q1 2015 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
| Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
| Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
| Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
| First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
| Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
| PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
| Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |